The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection

Head and neck (H&N) cancer is an aggressive disease and the incidence has increased in younger population worldwide. Tumour TNM staging is the main basis for treatment decision despite significant variation in clinical outcome. Survival time of these patients has marginally improved during the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Laytragoon Lewin, Nongnit, Lewin, Freddi, Andersson, Bengt-Åke, Löfgren, Sture, Rutqvist, Lars Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357467/
https://www.ncbi.nlm.nih.gov/pubmed/28316053
http://dx.doi.org/10.1007/s12032-017-0912-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357467/
https://www.ncbi.nlm.nih.gov/pubmed/28316053
http://dx.doi.org/10.1007/s12032-017-0912-7

Ejemplares similares